Please login to the form below

ICOs

This page shows the latest ICOs news and features for those working in and with pharma, biotech and healthcare.

GSK discontinues two feladilimab trials in head and neck cancer

Feladilimab aims to selectively enhance T cell function by stimulating ICOS, a protein found on the surface of certain T cells often found on a number of solid tumours. ... In November 2020, Jounce Therapeutics also announced that it would not expand a

Latest news

Celgene cuts back Jounce alliance ahead of BMS merger

Jounce now takes back full worldwide rights to the rest of its pipeline, including the ICOS-targeting vopratelimab, PD-1 inhibitor JTZ-4014 and all discovery programmes. ... BMS has its own anti-ICOS agonist, BMS-986226, in clinical trials and the
Wilmington Healthcare enhances digital platform, McCann recognised at IPA Effectiveness Awards

Courses on offer include What you need to know about NHS England's plan for ICSs and ICOs, which addresses how integrated care systems and integrated care organisations will start to
The NHS at 70: celebrations, renewed reforms and difficult choices

Key to the future of the health service in England will be the Integrated Care Organisations (ICOs), which aim to bring together health and social care services, both to improve patient ... At the moment there are 12m people in England covered by ICOs
Daily Brief: Tagrisso's first line approval, EULAR and EHA, and why Stephen Hawking was wrong on NHS

the lack of a legal framework is hampering the ICOs from making faster progress. ... Secondly, there has been considerable resistance against the changes, with campaigners claiming ICOs/ACSs are another backdoor privatisation of the NHS.
Bluebird and Celgene BCMA CAR-T kicks off ASCO

That includes data on Jounce Therapeutics’ ICOS-targeting antibody JTX-2011 which disappointed investors when the ASCO abstract was made public earlier this month, as well as Celldex’ anti-CD27 agonist

More from news
Approximately 2 fully matching, plus 18 partially matching documents found.

Latest Intelligence

Happy 70th birthday NHS: the next 70 need to be very different

Key to the future of the health service in England will be the Integrated Care Organisations (ICOs), which aim to bring together health and social care services, both to improve patient ... At the moment there are 12 million people in England covered by
30 Women Leaders in UK Healthcare (part 3)

ICOs (formerly known as Accountable Care Systems) require exceptional individuals who can break down the many institutional, cultural and financial barriers between hospitals, primary care and local authorities.
Deal Watch July 2016

It is a humanised inducible co-stimulator (ICOS) agonist antibody, designed to both stimulate T effector cells and selectively reduce intra-tumoural T regulatory cells.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

Wilmington Healthcare adds innovative new features to its digital learning platform for pharma and medtech

New courses on offer include: “What do you need to know about NHS England's plan for ICSs and ICOs?”, which addresses how integrated care systems and integrated care organisations will

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Senior Medical Copywriter - Highly Awarded Advertising Agency: £50,000 - £60,000 yearly

Home Based Account Manager, Medical Communications, UK, Pharma/M...: Highly competitive salary

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

Account Manager, Healthcare Marketing Creative Agency, Fixed ter...: Highly competitive salary

Account Manager, 6 month contract, Healthcare Brand communicatio...: Highly competitive salary

Account Director, Healthcare Marketing Creative Agency, Fixed te...: Highly competitive salary

AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer

PMHub

Add my company

fox&cat

Fox&cat is a new kind of fully-integrated communications agency – one that delivers genuinely inspirational campaigns and programmes with equal...

Latest intelligence

Patient Clinical Trial & Communications Plan Review: A Customer Story: ...
Working together to achieve better patient pathways: Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
Design-thinking. Iterating for continuous improvement.: How design can lead improvement within Pharma...

Email:
Password:

Please login to the form below

ICOs

Subscribe to our email news alerts

Quick links